BRIGHT SKY PROGRAM Trademark

Trademark Overview

On Thursday, June 13, 2019, a trademark application was filed for BRIGHT SKY PROGRAM with the United States Patent and Trademark Office. The USPTO has given the BRIGHT SKY PROGRAM trademark a serial number of 88472392. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 23, 2023. This trademark is owned by Astellas Pharma Global Development, Inc.. The BRIGHT SKY PROGRAM trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

providing medical and scientific research information in the fields of pharmaceuticals and clinical trials; and scientific study and research in the field of pharmaceuticals for treatment of menopause
bright sky program

General Information

Serial Number88472392
Word MarkBRIGHT SKY PROGRAM
Filing DateThursday, June 13, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 23, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 22, 2019

Trademark Statements

Disclaimer with Predetermined Text"PROGRAM"
Goods and Servicesproviding medical and scientific research information in the fields of pharmaceuticals and clinical trials; and scientific study and research in the field of pharmaceuticals for treatment of menopause

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, June 26, 2019
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAstellas Pharma Global Development, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNorthbrook, IL 60062
Party NameAstellas Pharma Global Development, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNorthbrook, IL 60062

Trademark Events

Event DateEvent Description
Monday, January 23, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, January 23, 2023ABANDONMENT - NO USE STATEMENT FILED
Friday, June 24, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 23, 2022SOU EXTENSION 5 GRANTED
Tuesday, June 14, 2022SOU EXTENSION 5 FILED
Thursday, June 23, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, June 14, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, March 30, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, March 30, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, March 30, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, November 18, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 16, 2021SOU EXTENSION 4 GRANTED
Tuesday, November 16, 2021SOU EXTENSION 4 FILED
Tuesday, November 16, 2021SOU TEAS EXTENSION RECEIVED
Wednesday, May 26, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 24, 2021SOU EXTENSION 3 GRANTED
Monday, May 24, 2021SOU EXTENSION 3 FILED
Monday, May 24, 2021SOU TEAS EXTENSION RECEIVED
Saturday, November 7, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, November 5, 2020SOU EXTENSION 2 GRANTED
Thursday, November 5, 2020SOU EXTENSION 2 FILED
Thursday, November 5, 2020SOU TEAS EXTENSION RECEIVED
Thursday, June 4, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 2, 2020SOU EXTENSION 1 GRANTED
Tuesday, June 2, 2020SOU EXTENSION 1 FILED
Tuesday, June 2, 2020SOU TEAS EXTENSION RECEIVED
Tuesday, December 17, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 22, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 22, 2019PUBLISHED FOR OPPOSITION
Wednesday, October 2, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 17, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, September 17, 2019EXAMINER'S AMENDMENT ENTERED
Tuesday, September 17, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, September 17, 2019EXAMINERS AMENDMENT E-MAILED
Tuesday, September 17, 2019EXAMINERS AMENDMENT -WRITTEN
Thursday, September 5, 2019ASSIGNED TO EXAMINER
Wednesday, June 26, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, June 17, 2019NEW APPLICATION ENTERED

Related Keywords

program bright research scientific pharmaceuticals study field treatment menopause trials clinical information